D. N. Franz Et Al. , "Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial," NEUROLOGY-CLINICAL PRACTICE , vol.8, no.5, pp.412-420, 2018
Franz, D. N. Et Al. 2018. Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial. NEUROLOGY-CLINICAL PRACTICE , vol.8, no.5 , 412-420.
Franz, D. N., Lawson, J. A., Yapici, Z., Ikeda, H., Polster, T., Nabbout, R., ... Curatolo, P.(2018). Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial. NEUROLOGY-CLINICAL PRACTICE , vol.8, no.5, 412-420.
Franz, David Et Al. "Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial," NEUROLOGY-CLINICAL PRACTICE , vol.8, no.5, 412-420, 2018
Franz, David N. Et Al. "Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial." NEUROLOGY-CLINICAL PRACTICE , vol.8, no.5, pp.412-420, 2018
Franz, D. N. Et Al. (2018) . "Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial." NEUROLOGY-CLINICAL PRACTICE , vol.8, no.5, pp.412-420.
@article{article, author={David N. Franz Et Al. }, title={Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial}, journal={NEUROLOGY-CLINICAL PRACTICE}, year=2018, pages={412-420} }